Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
about
Quantitative evaluation of myocardial fibrosis by cardiac integrated backscatter analysis in Kawasaki diseaseMyocardial Integrated Backscatter in Obese Adolescents: Associations with Measures of Adiposity and Left Ventricular Deformation.The insulin-like growth factor axis and collagen turnover during prednisolone treatment.Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy.Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model.A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonideMarkers of collagen metabolism and insulin-like growth factor binding protein-1 in term infantsMarkers of bone turnover in patients with epilepsy and their relationship to management of bone diseases induced by antiepileptic drugs.Growth, development and differentiation: a functional food science approach.Serum concentrations of procollagen I C-terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis imperfecta.Yunis-Varon syndrome: evidence for a lysosomal storage disease.Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy.Serum PICP as a bone formation marker in 89Sr and external beam radiotherapy of prostatic bony metastases.Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy.Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relation to height velocity and serum hormone levels.Serum levels of carboxyterminal propeptide of type I procollagen in healthy children from 1st year of life to adulthood and in metabolic bone diseases.Asthma, Glucocorticoids and Growth
P2860
Q30394049-50C89038-971D-4CAB-96EE-C7A56AD3C0D2Q30400150-51190A88-EF32-4FE5-B793-96576EF6F6ADQ33625194-C92321A1-8A91-4BB2-878D-E965E2390CFFQ34629550-53AC9FAE-7057-4F75-AAA3-D0AA161D8F02Q34797828-7DD32E33-5690-4211-A1B0-CD5ACA400455Q35156234-FF2D6EBC-12CA-4930-BF81-F01AC7AD077DQ35267839-A61FBC85-7347-44DF-BD5D-915DAA3BA401Q35289619-4B43FC86-AF4D-45B5-9464-9E438103AC0DQ38640619-656D0197-B03E-46BE-8766-E3332CBA654FQ40832219-9D1C4592-F990-44D5-A540-943370582C09Q41069074-23396BB4-415B-4734-8E5B-3FBD16F12DDCQ41924196-FA6D6CDD-0D74-4481-BD85-43B193257F8EQ44083774-7253D7A3-AF7C-4BDF-8C20-3190E0877ECBQ46009034-CBE0B305-C90C-424A-AE42-B87676DE1B7CQ47140449-A32EEF69-2C0F-4ACC-AFB4-83F4D4E2A4E0Q47314911-3A601192-F08E-4792-84F2-3F947848AE38Q54260813-C2A805B9-DFB9-4185-BB16-090572B346E9Q58250075-6172B31C-43F1-4227-87FC-5BC3B54FB7E6
P2860
Serum concentrations of the type I and III procollagen propeptides as biochemical markers of growth velocity in healthy infants and children and in children with growth disorders.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Serum concentrations of the ty ...... hildren with growth disorders.
@en
Serum concentrations of the ty ...... hildren with growth disorders.
@nl
type
label
Serum concentrations of the ty ...... hildren with growth disorders.
@en
Serum concentrations of the ty ...... hildren with growth disorders.
@nl
prefLabel
Serum concentrations of the ty ...... hildren with growth disorders.
@en
Serum concentrations of the ty ...... hildren with growth disorders.
@nl
P2093
P1433
P1476
Serum concentrations of the ty ...... hildren with growth disorders.
@en
P2093
P304
P356
10.1203/00006450-199109000-00016
P407
P577
1991-09-01T00:00:00Z
P5875
P6179
1043044386